positions available now

Tag Archives: Generic

Industry Insight – TGA Blueprint

Regardless of the type of therapeutic good you commercialise – original brand medicine, generic medicine, biological or medical device – we all share the common challenge of operating in a heavily regulated market. Therefore the role of the TGA in approving these products for market entry and maintaining marketability is paramount for commercial success in the pharmaceutical and medical device industry. In this Industry Insight we see how the TGA’s Blueprint reforms stack up and look at the impact on industry. Continue reading

Posted in Life Sciences Industry, Medical Services, Regulatory Services, TGA | Tagged , , , , | Comments Off on Industry Insight – TGA Blueprint

The Top 5: Opportunities from the Federal Budget

Here are five initiatives from the Budget we believe will offer commercial opportunities. Continue reading

Posted in E-Health/Technology, Federal Budget, Life Sciences Industry | Tagged , , | Comments Off on The Top 5: Opportunities from the Federal Budget
Copyright © 2020 Commercial Eyes